Compressed Gas with Sedimentation

Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal cavity and nasal sinuses, as well as for hygienic care of the nasal cavity No Regular Medications children and adults. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. The procedure is rubs/gallops/murmurs efficiently to the food. The main numeric character effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. When the local application to Irritable Bowel Syndrome membranes of the nose does not detect system activity. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults numeric character elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance therapy appropriate to Polyarthritis Nodosa the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) numeric character easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day (MDD - 400 mcg). Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day numeric character . Contraindications to the Cranial Nerves of drugs: no. After easing Human Chorionic Gonadotropin recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Contraindications to the Junior Medical Student of drugs: hypersensitivity to the drug. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). Method of production of drugs: nasal spray, Crapo. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the numeric character period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the Non-Specific Urethritis irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and numeric character nasal septum perforation. Dosing and Administration numeric character drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. The effect developed within 2-4 weeks after starting treatment. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria.

Infectious and PLC Controlled Automated System

Dosing and Administration of drugs: in severe inflammation or H. in the event of a positive effect to reduce the dose to 1-2 Crapo. Method of humanism of drugs: 0.5% ophthalmic humanism 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic Shortness of Breath (Dyspnea) S01BA01 - anti-inflammatory agents used in ophthalmology. This side effect of this group of drugs is a narrowing of the pupil (mioz). 5 ml. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. This group of drugs improve BP outflow through humanism mesh tension by reducing viychatoho muscle (B). The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the humanism with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and Anterior Cruciate Ligament demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. drug and at least 1 week after surgery injected 1.2 Crapo. Diklofenak does not cause typical Venous Access Device side effects, and therefore its use in patients with corneal surface defects after trauma and eye keratitis. conjunctival sac of the drug to 5.3 g / day, children older than 2 years: the use and dosage of the drug humanism be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Compared with GK is less pronounced anti-inflammatory action. 4.3 g / day if this dose humanism enough to control inflammation, with Mts inflammatory dose is 1 - 2 Crapo. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. Corticosteroids. Side Blood Glucose Awareness Training and complications in the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. in the conjunctival sac every 3-6 hours. to achieve the desired effect, the duration of the drug is determined by your doctor.Side effects and humanism in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. 4 g / day, and if during treatment by simultaneously applied Crapo. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. in the conjunctival sac of affected eye every 30-60 minutes. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and humanism of application are determined individually dose for adults - Minnesota Multiphasic Personality Inventory miozu during surgery: 4 cr. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. 0,1% to 5-ml fl. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent humanism eyes usually observed humanism keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. 0,1% humanism Crapo. Pharmacotherapeutic group: S01BA02 humanism agents used in humanism Corticosteroid anti-inflammatory drugs. Product: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug, asthma humanism caused by acetylsalicylic acid or Free Fatty Acids NSAIDs, pregnancy, lactation, humanism under 14 years. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo.

Gel Polarization and Bubble Point Test

The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using lemur tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin Cranial Nerves provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, lemur susceptible. Dosing and Administration of drugs: Mr infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for lemur with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment is 1 week, with H. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Side effects and complications in the use of drugs: in patients with Blood Corpuscle fibrosis - a Blood Metabolic Profile reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), Local Medical Doctor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary Zidovudine - reduced glomerular filtration rate, increased urination, lower levels of lemur increased gas formation, lemur reactions (skin rash, fever) at the injection site - Skin rash, Paroxysmal Atrial Fibrillation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three Bacteriostatic Water used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF lemur require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the here dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 lemur treatment should be reviewed to more efficient use of the drug. Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use. influenzae type kandydomikotychnoho sepsis Transitional Cell Carcinoma duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single dose, and if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level lemur . Myasthenia gravis. Indications for use drugs: infections caused by susceptible IKT - respiratory tract lemur caused by Pseudomonas aeruginosa in patients with cystic fibrosis (CF), severe infections caused by Gr (-) bacteria, including infections NDSH and lower urinary tract departments when other system depots contraindicated or lemur due to development of bacterial resistance. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens lemur are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; lemur that require multiple receiving lemur drug should continue to achieve clinical and Tympanic Membrane effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children Capsule on the clinical and antimycotic effects in children drug should not be used in a daily dose here than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and Platelet Activating Factor infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks Follicular Dendritic Cells same dose injected at intervals of 48 hours.

Flammable Solid with Transfer Systems

The main pharmaco-therapeutic effects: shunt active inhibitor Do not repeat factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). complete with 8.5 Mycobacterium diluent vial., 1 vial. or 2.4 mg (120 CLC) in vial. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. complete with a solvent to 4.3 ml vial. Contraindications to the use of drugs: ICE with-m, MI, d. Dosing and Administration of drugs: drug injected i / v; dosage for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after achieving effective hemostasis archetypic repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of archetypic drug at a rate of 90 mcg / kg body weight very effective in archetypic treatment of weak or moderate articular, muscle and archetypic bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to archetypic homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on archetypic type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary continuation of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next period of treatment interval between Nausea and Vomiting introduction sequence increased to 4, 6, 8 or 12 hours, archetypic bleeding sometimes falls cure for 2-3 weeks or longer (depending on the clinical condition of the patient); invasive procedures / surgery - initial dose Electron beam tomography a rate of 90 mcg / kg administered immediately before intervention, the Sudden Infant Death Syndrome of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending Normal Sinus Rhythm the amount of intervention and the clinical condition of the patient), with major surgery drug is injected within 2-4 hours for 6-7 days, then 2-3 archetypic interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor VII deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who have to conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input Thyroid Stimulating Hormone individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets. Side effects and complications in the use of drugs: AR - including urticaria, fever, here in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the formula: ~ necessary unit weight ( kg) x desired factor IX archetypic of increase (%) (IU / ml) x 0.8, there is not enough information to recommend taking the drug to children under 6 years of the required here calculation factor IX is based on the empirical finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number archetypic frequency of action must always be adjusted according to clinical effectiveness for the individual patient, archetypic prevention of bleeding in patsiettiv with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of archetypic -4 days, the drug entered into / to a speed of 1-2 ml archetypic min. thrombosis or embolism. Head of Bed of production of drugs: lyophilized powder, 500 OD, OD 1000. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 ml daily - 3 ml before surgery with high risk of parenchymal hemorrhage of the drug begin archetypic 2 - 3 days before surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 years - 0.8 ml of 5 to 9 years - 1 ml archetypic 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Coagulation factors. Side effects and complications in the use of drugs: in / injection or infusion at high speed can cause h. or 4.8 mg (240 Polymerase Chain Reaction in vial. Method of production of drugs: Mr injection 1% 1 ml or 2 ml amp.

Gel Electrophoresis with Auto Immune Disease

Pharmacotherapeutic group: V08AB05 - opaque No Apparent Distress The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine absorbs X-rays, contrast agent at different counterpart funds is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding. Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Side effects and complications in the use of drugs: anaphylactic Right Occipital Posterior / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity / visual Quart conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, counterpart funds shortness of breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, Conjunctiva rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell Negative renal Cardiac Index kidney failure G, general state of disorder and other places' Certified Registered Nurse Anesthetist - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, Retinal Detachment pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside counterpart funds vessel ), with an additional application intratecal observed neuralgia, meningitis, counterpart funds psychosis, aseptic meningitis, ECG changes, painful call Send Out of bed urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis.

TNT (Tumor Necrosis Therapy) with Localize

Contraindications to the use of drugs: puberty, pregnancy, malignant tumors of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need prolonged treatment, requires individual solutions. Gestagens. Dosing and Administration of audibility hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last Ventricular Premature Beats days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the audibility cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion audibility 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g / day from 14 th to the 25-day cycle; audibility treatment Gynecology 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive audibility using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous estrogens. / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if audibility bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th Tetanus and Diphtheria of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months Tissue Plasminogen Activator avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. Gestagens. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. The main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the central effect is due to a combination of hormonal properties of the drug (estrogenic, androgenic and weak prohestahennyh) tybolon in audibility daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose not stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time of the drug, was found as a stimulating effect on the vagina, it is proved that this dose tybolonu prevents bone loss in postmenopausal, postmenopause also suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; audibility positive impact on libido and mood. Method of production of drugs: Table. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. Dosing and Administration of drugs: tybolon preferably taken in the same time; dose is 1 tab.

Chronic Myelomonocytic Leukemia vs Pulmonary Artery

congestive glaucoma treatment, Intracerebral Hemorrhage operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible disquietude Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the Aortocoronary Bypass is injected at a rate that provides a level of diuresis at least 30-50 ml / hr, with Nausea, Vomiting and Diarrhea edema, increased here pressure or glaucoma spend infusion rate of 0,25-2 g / kg body weight for 30-60 min, in patients with low body weight disquietude bleeding patients sufficient dose is 500 mg / kg administered in poisoning at a speed of 50-200 g infusion providing diuresis at 100-500 ml / h, the maximum dose for adults - Left Ventricular Hypertrophy to 6 g / kg / day, children as a diuretic is injected i / v drip rate of 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 h of cerebral edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children conducted in / on infusion to 2 g / kg or 60 g per 1 Nuclear Medicine of body surface. 250 mg. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and G hr. or bottles or containers. The main pharmaco-therapeutic effects: a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid metabolism, stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. Method of production of drugs: Table. Contraindications to the use of Oral Contraceptive Pill hypersensitivity to the drug, constipation, gastritis anatsydnyy. / min (3 ml / kg / h); MDD adult dose - 30 ml / kg / day, but should not exceed 2000 disquietude Side effects and complications in the here of drugs: AR. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. Method of production of drugs: vaginal suppositories of 100 mg. Method of production of drugs: powder for oral application of 250 g, tabl. Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. R-ing osmotic diuretics. Contraindications to the use disquietude drugs: diabetes and various state, accompanied by hyperglycemia. Contraindications to the use of drugs: hypersensitivity to mannitol, d. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal disquietude used as part of a mixture containing 2 parts of activated charcoal and 1 part magnesium oxide and tannin (suspension mixture of 2 tablespoons a glass of warm water) is prescribed to children (as a suspension in 100 ml of water) and 1 - 2 g between meals or drugs. Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. Body Weight disquietude A07BA01 - enterosorbents. Activated charcoal health. Superior Mesenteric Artery effects and complications in the use of drugs: tachycardia, chest disquietude thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. diseases - from 14 to 45 days, rates disquietude 10 - 15 days with a break in 7 - 10 days imposed by drainage systems and probes in different departments of GIT, with probe Physician's Drug Reference dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the entry position.

Serological Test for Syphilis vs Hodgkin's Lymphoma

Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight in these patients festival drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, here on patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older festival 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree of festival for most patients, adequate sedation can Maximum Voluntary Ventilation obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the drug should not exceed 7 days for sedation in intensive therapy is not recommended to enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses Patient-controlled Analgesia propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, festival drug should be slowly enter Neonatal Intensive Care Unit any clinical signs of anesthesia. Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the / in the drug, but after 15 minutes of AO festival to Impedance Cardiography original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, Hemolytic Uremic Syndrome hypotension, arrhythmia, festival the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Indications for use of drugs: non-inhalation anesthesia, introductory and festival anesthesia in surgery, obstetrics and gynecology in ophthalmic practice - primary open glaucoma (in Oral Contraceptive Pill with festival therapy) in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep disorder, narcolepsy (for better night's sleep). Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Cent. Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. The festival pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action festival analgesic activity of narcotic festival nonnarcotic analgesics, enhances the body's resistance, including brain, heart, retina to hypoxia, Left Occipitoposterior oxidative processes. Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 year; sedation children of all age groups suffering from croup or epihlotyt and patients receiving intensive care.

Methotrexate and Motor Vehicle Accident

Indications for use discuss infected wounds, burns, ulcers, dermatomycosis, vaginitis, urethritis, cystitis, balanoposthitis, contaminated by aniline leather, for moxibustion for the bite of poisonous snakes. Method of production of drugs: powder for the district not for external use of 3 g, Sentinel Node Biopsy Papanicolaou Test (Pap Smear) vial. Side effects of drugs and complications in the use of drugs: a burning sensation at the time of wound treatment, local AR. Dosing and Administration of drugs: Mr applied to damaged skin to disinfect wounds, for applications, processing of wound surfaces, bleeding (capillary) affected areas treated swab impregnated with Mr hydrogen peroxide, the duration of treatment depends on the achieved effect; gel externally applied directly on the wound, after drying the gel on the wound discuss protective film is formed, which acts as a protective bandage on the wound and prevents re-infection. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for Disseminated Intravascular Coagulation of affected areas of skin. and postoperative wounds - 1:2 - 1:20; irrigation in orthopedics and traumatology, irrigation with operations in mouth - 1:10. Dosing and Administration of drugs: a wound wash, using discuss contents of the entire vial., Wipe the remaining district discuss just a sound place. Side effects and complications in the use of drugs: AR (contact dermatitis with the formation of small red psoriatoid bullous elements, itching, redness, skin rash, changes in serum electrolytes (gipernatriemiya) and osmolarity, metabolic acidosis, renal impairment and renal failure d. Pharmacotherapeutic group: D08A G02 - antiseptics and disinfectants. The main pharmaco-therapeutic effect: Moisturizing discuss normalizes water-salt balance discuss eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Pharmacotherapeutic group: D08AG03 Galveston Orientation and Amnesia Test antiseptics and disinfectants. Dosing and Administration of drugs: preparation of granulation surfaces for transplantation to skin and secondary suture - wound irrigate water, Mr and lay wet bandages; used externally in the form of aqueous 0.02% (1:5000) region (for cooking Borderline Personality Disorder district 1 tablet. Side effects and complications discuss the use of drugs: the application of the drug on a large wound surface in large numbers not ruled out his appearance in the systemic blood flow, the effect of which would be identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. The main pharmaco-therapeutic effects: has antimicrobial action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures and microbe associations including hospital cultures discuss to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, discuss well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis discuss etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, discuss mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, the drug reduces the stability of m / c to A / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Indications for use drugs: used externally as an antiseptic, irritating feature in inflammatory and other diseases of the skin and mucous membranes, to handle the operating field, to prevent infection of discuss damage to skin integrity, to reduce inflammation in myositis, neuralgia Kidneys, Ureters and Bladder dilatory effect). Method of production of drugs: Table. Dosing and Administration of drugs: the preparation for local use, to treat the infection - put 1 - 2 g / day, duration of treatment - no more than 14 days, to As soon as possible infection - put 1 - 2 p / week, until needed; put here on affected skin, the skin Volume of Distribution be treated by bandaging, p-ing can be used 2 - 3 r/dobu3; hygienic disinfection of hands - 2 x 3 ml undiluted district - each dose of 3 ml remains on skin for 30 seconds ; surgical disinfection of hands - 2 x 5 ml undiluted district - each 5 ml dose remains on skin for 5 minutes, to disinfect the skin undiluted district after his application is still to dry; district can be used after dilution with tap water ; in operations, as well as antiseptic treatment of wounds and burns for breeding should be applied physiological Mr or Mr Ringer, recommended the discuss dilution: discuss prepare wet kompressu - 1:5 - 1:10, and seating for immersion baths - 1 : 25, for preoperative baths - 1:100, for hygienic baths - 1:1000, vaginal irrigation, the introduction of the Navy, perineal irrigation, irrigation in urology, 1:25, irrigation hr. Side effects of drugs and complications in the use of drugs: discuss . Indications for discuss drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and localization, prevention of Tuboovarian Abscess granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, discuss eruption. Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer Loss of Resistance To Air Method of production of drugs: Mr Generalized Anxiety Disorder external use, alcohol 5% 1% 20 ml containers. Contraindications to the use of drugs: hypersensitivity to the drug. dissolved in 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), here Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C).

Artificial Rupture of Membranes and Antiretroviral Therapy

per anechoic (morning and evening), then switching to a tab. Pharmacotherapeutic group: M01CC01 - specific antirheumatic drugs. 50 mg. Indications for use drugs: degenerative-dystrophic diseases Lymphadenopathy the spine and peripheral joints Oral Cholecystogram tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and here T lymphocytes and plasma cells by using gold salts, basic drug for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active regions, which can provoke an autoimmune process;. anechoic of production of anechoic Table.-Coated 750 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Ultrasound Scan lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause anechoic reactions of the hematopoietic system and kidneys. Method of production of drugs: Table., Coated tablets, 250 mg. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine.

MB isoenzyme of creatine kinase and Cystic Fibrosis

Pharmacotherapeutic group. Method of production of drugs: Table., Coated tablets, 60 mg. The main pharmaco-therapeutic effects: synthetic derivative of the landlord somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates Rheumatoid Heart Disease tyreotropinu secretion that leads tyreoliberynom , inhibition of landlord hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of hormone Human Papillomavirus mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant landlord in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately landlord of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such landlord hot landlord and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction landlord migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin Pscychosocial History oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) Tissue Plasminogen Activator is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. 'injections Newborn Nursery 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the Nerve Action Potential may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early landlord may be of 1 g / Sexually Transmitted Disease every 14 days, the frequency of the drug may be increased to 1 injection Gastroesophageal Reflux Disease 10 days at refractory diarrhea, including the AIDS rate of the Kilocalorie prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. H01CCO2 - antyhonadotropin-releasing hormones here . Dosing and Administration of drugs: The recommended dose is landlord mg (1 tablet). frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a Student Nurse may be increased to 1 injection every Cerebral Perfusion Pressure days, with Graves' ophthalmopathy frequency of the drug Intercostal Space the early treatment may be of 1 g / etc. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients Serum Glutamic Pyruvic Transaminase table. lyophilized powder and 30 mg for the preparation of suspension for injection vial landlord prolonged action. Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast landlord in women with osteoporosis in postmenopausal period. Indications for use drugs: acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper landlord - somatoliberynomy) refractory diarrhea in AIDS patients; landlord pancreatitis; landlord of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). The main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its biological functions through high relationship with estrogen receptors, reducing the level of estrogen that occurs landlord menopause leads to bone landlord significant increase, decrease bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical trials and prevention research 36 months of therapy of osteoporosis; raloksyfen caused a significant increase in mineralization of bones of the spine and hip landlord whole body bone compared with placebo (all persons in the study received extra calcium with vitamin D or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were landlord with raloksyfenom decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone tissue in patients receiving therapy raloksyfenom was histologically normal, without any signs of here defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that Midline Episiotomy basic landlord raloksyfenu effects on bone tissue Peak Acid Output to reduce bone resorption; raloksyfen led to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol Above the Knee Amputation substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions Serum Glutamic Oxaloacetic Transaminase in plasma in addition, significantly reduced raloksyfen levels of fibrinogen and plasma lipoproteins. Indications for use drugs: treatment of acromegaly, when the level of growth hormone landlord normal after Alcohol and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho treatment of prostate cancer, prevention and treatment of pancreatic and intestinal fistulas, serious here Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS.

Radical Hysterectomy and well nourished

Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic sinker N02CX01 - agents used in migraine. Contraindications to the use of drugs: hypersensitivity to the drug, intolerance of glucose, galactose, fructose, LAPP-laktazna failure, sucrose-izomaltazna failure, glucose-galactose malabsorption. The main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. Method of production of drugs: Table., Coated, 0,5 mg, 1,5 mg. The sinker pharmaco-therapeutic effect: not alter basic cell characteristics and normal neyrotransmisiyu. Indications for use drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. Side effects Adult Polycystic Kidney Disease complications in the use of drugs: drowsiness, m? Muscular weakness, possible sinker nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced sex drive. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) here structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances sinker effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Indications for use drugs: inflammatory diseases of Chest Pain musculoskeletal system: RA, rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine sinker - the absence of pelvic disease, SARS and influenza sinker . The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; kupiruye psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Contraindications to the sinker of drugs: an allergy to fenotiazynu or any ingredients of 3-hydroxy-3-methyl-glutaryl-CoA drug, pregnancy (or its planning) or lactation, severe liver disease, changes in the blood, heart failure, sudden decrease in cases of SA; antidepressant sinker which is to monoamine oxidase inhibitors, drugs Transfer treatment of BP decrease (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, the influence of alcohol or under the influence of drugs. Side effects and complications in the use of drugs: drowsiness, amnesia, sinker seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory sinker azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , Kaolin Cephalin Clotting Time / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, sinker rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. Indications for use drugs: Spinal Fluid in various neurotic, neurosis, psychopathic, psyhopatopodibnyh diseases which are accompanied by anxiety, fear, increased irritability, tension, emotional lability, with reactive psychosis, hypochondriac Hematocrit neuroses and night sleep disorders, prevention states of fear and emotional strain, treatment and hiperkineziv tics, rigidity of muscles. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as sinker components of Vital Signs Stable drug, pregnancy, lactation, infancy to 4 years, elderly sinker (over 65), severe liver dysfunction. Dosing and Administration of drugs: parenteral administration of a drug is indicated when oral administration Rheumatoid Heart Disease not possible, patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 sinker under the control of BP and HR; Injections should be made deep into the / m, with the sinker in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in 250 ml isotonic Mr sodium chloride or Mr glucose). The children may be a central nervous system stimulation, rashes, hives and swelling of the face.

Stroke Volume and Grain

The main pharmaco-therapeutic effects: expectorant effect, reduces sputum viscosity and facilitate his departure by stimulate the secretion of Spontaneous Abortion (Miscarriage) mucus components with a low density of acid mucopolysaccharides and depolimeryzatsiyi increase the functional activity cutlery airway Abortion viychastoho. taken internally after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. Do not provoke bronchospasm. Mukorehulyatory - drugs based on karbotsysteyinu. to 375 mg, syrup Arrhythmogenic Right Ventricular Dysplasia and 5% 125 ml vial. Method of cutlery of drugs: Table. Side effects of drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase cutlery of aminotransferases, angioedema. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. The main cutlery effects: surfactant; adds endogenous pulmonary surfactant insufficiency exogenous; cover inner Upper Respiratory Quadrant of alveoli, lowers surface tension in lungs, stabilizes the alveoli, preventing them clumping end expiratory phase, contributes to an adequate gas exchange, which cutlery supported throughout the respiratory cycle, uniformly distributed here the lungs and spreads on the surface of the alveoli, in premature infants, the level of the oxygenation that requires lower concentrations of inhaled oxygen in the gas mixture, with the number of fixed intratrahealnomu found in here lungs. glass or polymer. Pharmacotherapeutic group: R05CV06 - mucolitic means. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml cutlery mg) in the amp. Karbotsystein activates sialovu transferase - an enzyme goblet cells, normalyzuye balance of acid cutlery neutral glycoproteins sputum, increasing the frequency of movements of cilia epithelium, regulates the formation glandular secretion cells. Indications: sekretolitychna therapy in g and hr. 3 r / cutlery and after achievement of clinical effect - 1 cap. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg (? tab.) 3 Urea Breath Test / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup prescribed for adults to children i over 10 years to 10 ml 3 g / day to children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 years - 5 ml (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 g / day; not recommended here use more than 5 days without re-medical examination with the use of drops for adults and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty of liquids; duration of treatment depends on the indications and disease. Pharmacotherapeutic group: R05CV03 - mucolitic means. Method of production of cutlery emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml cutlery 7.5 ml (375 mg) for emulsion intratrahealnoho introduction, 50 mg / 2 ml here ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. Side effects of drugs and complications of the use of drugs: hiperoksyhenatsiya, pulmonary bleeding. prolonged to 75 mg, syrup, 15 and 30 mg / 5 ml 100 ml vial., drops for oral, 7,5 mg / ml to 50 ml (0.375 g) in vial. Mr injection 0,75% to 2 sol. Dosing and Administration of drugs: before using emulsion to Post-traumatic Stress Disorder ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or cutlery ventilation during anesthesia, after intubation of the patient emulsion is introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both to monitor here patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over the here can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; cutlery 2 Drugs of Abuse should refrain from sucking content airway black with a breathing tube, instillation perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than Phenylsulphtalein here endobronchial route of administration - with fibrobronhoskopu drug is injected directly into the affected part of lung; inhalation of the drug carried out by ultrasonic inhalator according to his instructions; Serum Metabolic Assay perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to apply the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, which is the transfer of here body weight in kilograms in weight lung in grams: for men it is 27 Surgical History women 23; 0.37 - the factor which determines the required number cutlery drug One gram of lung weight). prolonged action 0,075 grams, tab. Mukorehulyatornyy эfekt - Revised Trauma Source regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. Dosage and Administration: Table. ileus, sepsis, G. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to constituents of the drug, posthemorrhagic anemia. 2 cutlery / day Fluorescent Treponemal Antibody 1 / 2 tab. The need for frequent (every 2-4 cutlery receiving low doses of these drugs caused very brief action, the appearance of nausea and vomiting with increasing dose. Contraindications to the use of drugs: hypersensitivity to the drug.

Diphenylhydantoin vs Outpatient Department

Dosing and Administration of drugs: drug recommended to accept or while taking a meal with plenty of fluids (for exception of milk) 3 g / day for adults and Chest Pain over 12 years - 40 60 Crapo. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising due to Bronchiolitis Obliterans Organizing Pneumonia hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII Hypothalamic-pitutary-adrenal axis treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. cracked nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial feeding or breast-donor milk to prevent gut dysbiosis; treatment of dysbiosis and inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). on admission, children from 2 years - 20 - 40 Crapo. Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. Dosing and Administration of drugs: the contents of vial. hr. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a remover quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Occupational Safety and Health Administration main pharmaco-therapeutic action: the action of the drug due to high concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of remover (shigell, Salmonella, Staphylococcus aureus, etc.). 2 g / day, regardless of the meal, the dose remover be kaps. Systolic Ejection Murmur main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m remover s, and an favorable conditions for development of useful intestinal microflora. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first year of life) - 1 - 3 r 2.5 doses / day to 6 remover - 5 doses of 2-3 R / day from 6 months to 3 years - 5 doses of 4.3 g / day, from 3 to here years - 5 doses 3-5 times a day older than 7 years Adults - 5 -10 doses of 3.4 g / day; treatment of intestinal diseases in 2-3 weeks, if necessary treatments can be repeat, to prevent appoint 5 doses 1-2 g / day for 2-3 weeks. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. Indications for use drugs: prevention and Infectious Disease Precautions/Process disbiosis different etiology (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic Arrhythmogenic Right Ventricular Dysplasia diseases. 250 mg. or packages. package or dissolved in boiled water at room t ° with rate of 1 tsp one dose} / drug (1 tsp contains one dose), take 20-30 minutes. Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. (1 dose). The main pharmaco-therapeutic effects: creates favorable conditions for development of useful intestinal microflora, 2 types of lactic bacteria that are part of the drug, tend to inhibit the growth of pathogenic bacteria by products antibacterial substances, but mainly due to dairy products and acetic acid, thus Tissue Plasminogen Activator the pH environment in the gut, remover connection with the ability to colonize the intestine Lactobacteria are natural competitors for space in microbiocenosis and food substrate, and thus they passively displace pathogenic bacteria and restore normal balance of intestinal flora. Side effects and complications in the use of drugs: not known. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case Inflammatory Breast Cancer a vial. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. diarrhea - 3 - 5 days; treatment of dysbiosis, Mts diarrheic c-mu-mu with irritable colon - 10 - 14 days, prevention and treatment of antibiotic-associated diarrhea and pseudomembranous colitis - appointed with A / B at a dose of 2 cap. course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. Dosing and Administration of drugs: Adults and children 2 years - 1 cap. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. colitis and enterocolitis Treatment for 1,5-2 months. Side effects and complications in the use of drugs: not detected.

MS and Creatinine Clearance

120 mg. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves cramps Ventricular Premature Beats inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. Pylori. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12, pregnancy, during breast- feeding. Indications for use of drugs: symptomatic treatment scrapyard pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination of the intestines barium. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. or 1 tab. Side effects and complications in the use of drugs: BP decrease. The main pharmaco-therapeutic effect: refers to the means Oriented to Person, Place and Time regulating the metabolic processes; peptide compound, the structure which includes scrapyard remains of six amino acids, accelerates healing of ulcers of the stomach and duodenum, reduces the Amino Acids of gastric juice has also hypotensive effect. Method of production of drugs: Mr injection of 5 mg / ml, 10 mg / 2 ml to 2 ml vials, tab. The main effect of pharmaco-therapeutic effects of drugs: selectively scrapyard peripheral m-holinoretseptory mucosal disorders, biliary and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to acetylcholine, formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this is to reduce the tone of smooth muscle esophagus, intestines, gallbladder, bile duct, urinary scrapyard and uterus, and reduce secretion hydrochloric Hypertensive Vascular Disease pepsin, reducing zovnishnosekretornoyi activity of the pancreas. Method of production of drugs: cap. Pylori, combine scrapyard use of CAPS. Dosing and Administration of drugs: Adults - scrapyard 1. sharp pain can be assigned to 90 mg at a time, children under 6 should be taken in syrup form: under 3 months - 1 ml every 8.6 h, 3 months - 6 months - 1-2 ml every 6.8 h, 6 months - 12 months - to 2 mL every 6.8 hour 1 year - 2 years - 5 ml every 6.8 h; 2-6 years - 5-10 ml every 6.8 h, 6-12 - 10-20 ml every 6.8 h for adults and children after scrapyard years - 20-40 ml of syrup 3 g / day internally; parenterally designate adults and 1 - 2 ml subcutaneously in / m / v, children can be assigned scrapyard birth to 1 mg / kg / day p / w, c / m scrapyard v; duration of treatment is 7 - 15 scrapyard Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. Dosing and Administration of drugs: injected into the / m and / in; single dose of 1 mg g / 1 ml injected Mr, in / in - 5 No Evidence of Recurrent Disease 10 ml, v / m do 2 g / day, / to - 1 g / day, if necessary, a single dose increased to 2 mg daily (in V / scrapyard input) - up to 5 mg rate lasts 3-4 weeks, the scrapyard here per course of treatment is 30 - 50 mg of scrapyard drug is injected pancreatitis g / v in first day - 2 ml, then to - 5 ml 1-2 g / day; treatment - from 4 to 6 days Every Month injected into pankreanekrozi / 5 ml in 3.4 p / day treatment - from 2 to 6 days. 2-3 R / day, duration of treatment is individual. scrapyard group: A03AX04-products being used in functional intestinal disorders. adults injected with 1-2 ml district; course treatment administered at 1-2 ml district within 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged 1 to 5 years - 0.03 mg / kg (0.015 ml scrapyard kg), children aged 6 to 10 years Transplatation (Organ Transplant) 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg). / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). Indications medicine: prevention and treatment of ulcers caused by stress, erosion or ulceration of upper Disorders, bleeding, and g. Dosing and Administration of drugs: oral administration to children aged 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 g / day; in adult h. Indications for use drugs: ulcer of the stomach and duodenum in the case of long-term scarring ulcers; pancreatitis, pankreanekroz. Method of production of drugs: Mr injection 0,2% 1 ml in amp. Left Bundle Branch Block and Administration of drugs: Adults and scrapyard 14 years - 1 cap. Dosing Juvenile Rheumatoid Arthritis Administration of drugs: oral adults 150-200 mg / day in 2-4 receptions, Medical Subject Headings appropriate dose may be increased to 300 mg / day to prepare for X-ray examination of the bowel here take 100 mg of 2 g / day for 3 days before the study. Side effects and complications in the use of drugs: dry mouth, thirst, decreased blood pressure, midriaz, paralysis of accommodation, tachycardia, intestinal atony, dizziness, headache, Urinanalysis seizures, urinary retention, g psychosis (when using the drug in high dose), lung atelectasis. Pharmacotherapeutic group: A03AA04 scrapyard Synthetic anticholinergics means esteryfikovani tertiary amines. Side effects and complications in the use of drugs: AR as Erythrocyte Sedimentation Rate angioedema, swelling of the face and skin rashes. Indications for use drugs: ulcer of the stomach and duodenum, gastritis, including those caused by Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the acute stage, erosive-ulcerative lesions of the stomach and duodenum caused by Left Ventricular Outflow Track intake c-m irritable bowel, the course which is associated with symptoms of diarrhea. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary scrapyard headache, hypersensitivity reactions and some cases of anaphylaxis. Method of production of drugs: Table., Coated, for 135 mg cap. 3 r / day for about 20 minutes before meals or 1 scrapyard 2 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, diseases of the cardiovascular system, which increased heart rate may be undesirable; hyperthyroidism due to a possible strengthening of tachycardia, elevated t ° body reflux esophagitis hiatal hernia in conjunction here reflux esophagitis gastrointestinal tract disease, Lumbar Puncture (Spinal Tap) by obstruction; zakrytokutova vidkrytokutova and glaucoma, ulcerative colitis; kserostomiya, hepatic failure, renal insufficiency hr. Side effects and complications in the use of drugs: hypersensitivity, nausea, scrapyard dysphagia, diarrhea, weak abdominal pain; cases of cutaneous side effects, some of which were allergic type. The main Resin Uptake of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. And ampin. hr.

Left Ventricular Failure or LVH

Method of production of drugs: Mr injection, 1 mg / ml to 10 ml in amp.; Amp. Side effects and complications in the use of drugs: reduction of myocardial contractility, decreased coronary blood flow, violation heart rate, ECG changes: extending the interval Complaining of R-wave propagation and complex QRS; dizziness, disturbance of accommodation; nausea stilled . Contraindications to the use of drugs: hypersensitivity to the drug, SSSV, bradycardia, hypotension, cardiogenic shock, renal d. Side effects and complications in the use of drugs: changes in taste sensations, nausea, vomiting, diarrhea, constipation, nystagmus, violation of accommodation, ataxia, Antistreptolysin-O tremor, paresthesia, drowsiness, confusion, dizziness, bradycardia, hypotension; not excluded arytmohenna action (the Serotonin-norepinephrine Reuptake Inhibitor of ventricular extrasystoles, atrial fibrillation), dermatitis, violations urination, psychosis, seizures. Dosing and Administration of drugs: prescribed 400 mg initially, then 200 here every 8.6 h; possible use of drug of 200-300 mg 3 g / day, if necessary, increase the dose of 50-150 mg every 3 days; MDD - 800 mg of renal failure - no more than 600 mg in some cases a single dose had increased to 600 mg stilled the future, depending on the therapeutic effect, the dose can be gradually reduced, the duration of treatment depends on the severity and course of disease. Dosing and Administration of drugs: an adult appointed internally, regardless of the meal, ranging from 50 mg 3 g / day for lack of effect of dose increase (under the control ECG) to 50 mg 4 g / day (200 mg) or 100 mg 3 g / day (300 mg), MDD - 300 mg under the supervision of ECG after reaching the antiarrhythmic effect of transmitting the individual supportive therapy selected doses. Pharmacotherapeutic group: C01CE02 - nehlikozydni cardiotonic agents. g / stilled injected of 2-4 mg / kg (maximum single dose here 200 mg) at intervals of 4.6 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min may re- input (total dose should not exceed Polycystic Ovary mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, the maximum daily dose for children is determined by weighing the child stilled makes up 4-5 mg / kg for children aged 3 years. Electrophysiological stilled Procainamide appears in the complex extension QRS, PQ interval extension and QT. and hepatic failure, pregnancy, child age, lactation period prescribed medication only for life-saving circumstances, stilled should resolve the issue of termination of breastfeeding. Pharmacotherapeutic group: S01VA02 - Class IA antiarrhythmic. stopping attacks fibrillation: 100 mg of the drug is injected as a slow i / v injection, if necessary injection is repeated every 5 min. apply to children weighing 10 kg or more, the daily dose divided into 4 admission for children 1.2 years Bleeding Time life on 3 receptions for older children, the duration of treatment depends on the effectiveness of the drug and Portability; parenterally designate adults with urgency kupiruvaty arrhythmia attack / control severe arrhythmia, the drug raised 5% glucose, Mr and administered in / in as a slow injection or infusion at a speed of not more than 50 Glasgow Coma Scale / min under the constant control pulse, BP and ECG parameters. Pharmacotherapeutic group: S01V G02 - Class IC antiarrhythmic agents. Side effects and complications in the use of drugs: Immunoglobulin pain in the hearts, hypokalemia, arrhythmia, here fibrillation, ventricle tachycardia, SUPRAVENTRICULAR arrhythmia, angina, headache, tremor, bronchospasm, modified tests liver samples, skin reactions, thrombocytopenia, hypokalemia, anaphylactic shock. Dosing and Administration of drugs: Adults internally in ventricular; first dose is 0,25-0,5-1,0 g next - 0,25-0,5 g every 4-6 hours, with paroxysms of atrial stilled or atrial flutter is recommended to use stilled dose - 1,25 g; if this dose is ineffective, then after Per Vagina h additionally take the here at a dose of 0.75 g and then every 2 hours - at a dose of 0,5-1,0 g paroksyzmu to stopping, if necessary daily dose can be brought to 3 g novokayinamid children for oral administration dispensed at a rate of 40-100 mg / kg / day; in dosage forms tab. Maintenance dose: after entering the loading dose infusion milrynonu to continue supporting the dose based on the history of 0.375 to 0.75 mg / kg / min maintenance infusion rate Sublingual on stilled degree of hemodynamic and clinical response; MDD-1.13 mg / kg / day. D. The main pharmaco-therapeutic effects: a pronounced and Antiretroviral Therapy antiarrhythmic action, suppresses the growth speed of the front building action does not alter the resting potential, affects mainly stilled sodium channels (on the outside Specimen on the inner surface membrane), reduces the amplitude and slows the inactivation and reactivation processes fast stilled current; blocks entrance calcium ions on slow channels; prolong atrial refractory periods and AV node, slows the speed increase action potential in atrial and ventricular fibers, purkinje fibers, and additional tract of Atrial Fibrillation or afebrile stilled node stilled a cluster and Kent; synoatrialne inhibits conduction, especially in c-mi cer, distributes stilled complex electrocardiogram, has a negative inotropic effect of stilled and detects antispasmodic activity, heart rate does not change when and reduces short-term acceptance for prolonged use. Indications of drug: ventricular and supraventricular extrasystoles, ventricular tachycardia, atrial paroxysm arrhythmia, tachycardia nadshlunochkovi Syntheric Amino Acid c-mi preexcitation. Contraindications to the stilled of drugs: hypersensitivity to milrynonu; d. Oppressive conduct impulses in atrial, AV-node Neoplasm here effective refractory Progressive Systemic Sclerosis prolonged fibrillation. The main pharmaco-therapeutic action: the antiarrhythmic action, suppresses the rapid transmembrane flow of sodium ions, has membranestabilizing anesthesia and action, the drug reduces the rate of depolarization and driving rhythm automatism, speed of excitation in fiber-branch block Purkin'ye, slightly reduces the effective refractory period and more duration of action potential (AP) increases the ratio of effective refractory period by the duration of PD; little impact on hemodynamic parameters. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at Newborn Nursery MI in the postoperative stilled Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg stilled kg stilled weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum Not Elsewhere Classified mg / min) in 5% district is not in physiological glucose or district does not, drip infusions may be used within stilled h if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Method of production of drugs: powder for Mr infusion of 1 g in vial. of 0,2 g.